Semin Thromb Hemost 2019; 45(02): 150-156
DOI: 10.1055/s-0039-1678720
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Thromboprophylaxis in Patients with Acute Spinal Cord Injury: A Narrative Review

Siavash Piran
1   Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada
,
Sam Schulman
1   Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada
2   Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
11. Februar 2019 (online)

Abstract

Patients with acute spinal cord injury (SCI) have the highest risk of venous thromboembolism (VTE) among hospitalized patients. The incidence of total deep vein thrombosis ranges from 50 to 100% in untreated patients and pulmonary embolism is the third most common cause of mortality in these patients. The pathophysiology of the increased risk of VTE is explained by venous stasis after injury, endothelial vessel wall injury from surgery, and a hypercoagulable state associated with trauma. The current thromboprophylaxis options are limited, with low-molecular-weight heparin (LMWH) being the current standard of care. LMWH is commonly administered for 3 months, during which period the risk of VTE is especially high. Some uncertainty exists regarding the optimal timing to initiate pharmacological thromboprophylaxis and the best regimen of LMWH prophylaxis. High-quality data are currently lacking in thromboprophylaxis in patients with SCI. Many questions in this area remain to be answered, which are described in this narrative review.

 
  • References

  • 1 Piran S, Schulman S. Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: a retrospective study. Thromb Res 2016; 147: 97-101
  • 2 Clements R, Churilov L, Wahab AL, Ng LC. Exploratory analysis of factors associated with venous thromboembolism in Victorian acute traumatic spinal cord-injured patients 2010-2013. Spinal Cord 2017; 55 (01) 74-78
  • 3 Chen H-L, Wang X-D. Heparin for venous thromboembolism prophylaxis in patients with acute spinal cord injury: a systematic review and meta-analysis. Spinal Cord 2013; 51 (08) 596-602
  • 4 Giorgi Pierfranceschi M, Donadini MP, Dentali F. , et al. The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study. Thromb Haemost 2013; 109 (01) 34-38
  • 5 Merli GJ, Crabbe S, Paluzzi RG, Fritz D. Etiology, incidence, and prevention of deep vein thrombosis in acute spinal cord injury. Arch Phys Med Rehabil 1993; 74 (11) 1199-1205
  • 6 Green D, Twardowski P, Wei R, Rademaker AW. Fatal pulmonary embolism in spinal cord injury. Chest 1994; 105 (03) 853-855
  • 7 DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil 1999; 80 (11) 1411-1419
  • 8 Piran S, Bednar D, Drew B, Schulman S. Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: a survey of Canadian spine surgeons. Thromb Res 2017; 160: 38-40
  • 9 Owings JT, Gosselin R. Acquired antithrombin deficiency following severe traumatic injury: rationale for study of antithrombin supplementation. Semin Thromb Hemost 1997; 23 (01) (Suppl. 01) 17-24
  • 10 Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331 (24) 1601-1606
  • 11 Green D, Hartwig D, Chen D, Soltysik RC, Yarnold PR. Spinal cord injury risk assessment for thromboembolism (SPIRATE study). Am J Phys Med Rehabil 2003; 82 (12) 950-956
  • 12 Jones T, Ugalde V, Franks P, Zhou H, White RH. Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children. Arch Phys Med Rehabil 2005; 86 (12) 2240-2247
  • 13 Chung SB, Lee SH, Kim ES, Eoh W. Incidence of deep vein thrombosis after spinal cord injury: a prospective study in 37 consecutive patients with traumatic or nontraumatic spinal cord injury treated by mechanical prophylaxis. J Trauma 2011; 71 (04) 867-870 , discussion 870–871
  • 14 Selassie AW, Varma A, Saunders LL. Current trends in venous thromboembolism among persons hospitalized with acute traumatic spinal cord injury: does early access to rehabilitation matter?. Arch Phys Med Rehabil 2011; 92 (10) 1534-1541
  • 15 Worley S, Short C, Pike J, Anderson D, Douglas JA, Thompson K. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study. J Spinal Cord Med 2008; 31 (04) 379-387
  • 16 Maung AA, Schuster KM, Kaplan LJ, Maerz LL, Davis KA. Risk of venous thromboembolism after spinal cord injury: not all levels are the same. J Trauma 2011; 71 (05) 1241-1245
  • 17 Chung WS, Lin CL, Chang SN, Chung HA, Sung FC, Kao CH. Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with spinal cord injury: a nationwide cohort prospective study. Thromb Res 2014; 133 (04) 579-584
  • 18 Wells PS, Anderson DR, Rodger M. , et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349 (13) 1227-1235
  • 19 Linkins LA, Bates SM, Lang E. , et al. Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med 2013; 158 (02) 93-100
  • 20 Matsumoto S, Suda K, Iimoto S. , et al. Prospective study of deep vein thrombosis in patients with spinal cord injury not receiving anticoagulant therapy. Spinal Cord 2015; 53 (04) 306-309
  • 21 Mackiewicz-Milewska M, Jung S, Kroszczyński AC. , et al. Deep venous thrombosis in patients with chronic spinal cord injury. J Spinal Cord Med 2016; 39 (04) 400-404
  • 22 Masuda M, Ueta T, Shiba K, Iwamoto Y. D-dimer screening for deep venous thrombosis in traumatic cervical spinal injuries. Spine J 2015; 15 (11) 2338-2344
  • 23 Furlan JC, Fehlings MG. Role of screening tests for deep venous thrombosis in asymptomatic adults with acute spinal cord injury: an evidence-based analysis. Spine 2007; 32 (17) 1908-1916
  • 24 Gould MK, Garcia DA, Wren SM. , et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (02) e227S-e277S
  • 25 Teasell RW, Hsieh JT, Aubut JA, Eng JJ, Krassioukov A, Tu L. ; Spinal Cord Injury Rehabilitation Evidence Review Research Team. Venous thromboembolism after spinal cord injury. Arch Phys Med Rehabil 2009; 90 (02) 232-245
  • 26 Marciniak CM, Kaplan J, Welty L, Chen D. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy. PM R 2012; 4 (01) 11-17
  • 27 Geerts WH, Jay RM, Code KI. , et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996; 335 (10) 701-707
  • 28 Green D, Lee MY, Lim AC. , et al. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin. Ann Intern Med 1990; 113 (08) 571-574
  • 29 Halim TA, Chhabra HS, Arora M, Kumar S. Pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury: an Indian perspective. Spinal Cord 2014; 52 (07) 547-550
  • 30 Lohmann U, Gläser E, Braun BE, Bötel U. Prevention of thromboembolism in spinal fractures with spinal cord injuries. Standard heparin versus low-molecular-weight heparin in acute paraplegia [in German]. Zentralbl Chir 2001; 126 (05) 385-390
  • 31 Spinal Cord Injury Thromboprophylaxis Investigators. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. J Trauma 2003; 54 (06) 1116-1124 , discussion 1125–1126
  • 32 Geerts WH, Bergqvist D, Pineo GF. , et al. Prevention of venous thromboembolism: American College of Chest Physicians. Evidence Based Clinical Practice Guidelines (8th edition). Chest 2008; 133: 381S-453S
  • 33 Chiou-Tan FY, Garza H, Chan KT. , et al. Comparison of dalteparin and enoxaparin for deep venous thrombosis prophylaxis in patients with spinal cord injury. Am J Phys Med Rehabil 2003; 82 (09) 678-685
  • 34 Hebbeler SL, Marciniak CM, Crandall S, Chen D, Nussbaum S, Mendelewski S. Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury. J Spinal Cord Med 2004; 27 (03) 236-240
  • 35 Slavik RS, Chan E, Gorman SK. , et al. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: ‘DETECT’ trial. J Trauma 2007; 62 (05) 1075-1081 , discussion 1081
  • 36 Fehlings MG, Tetreault LA, Aarabi B. , et al. A clinical practice guideline for the management of patients with acute spinal cord injury: recommendations on the type and timing of anticoagulant thromboprophylaxis. Global Spine J 2017; 7 (3, Suppl): 212S-220S
  • 37 Bono CM, Watters III WC. , eds. NASS Evidence-Based Guideline Development Committee. Anti-thrombotic Therapies in Spine Surgery. North American Spine Society Evidence-Based Clinical Guidelines for Multidisciplinary Spine Care; Burr Ridge, IL: North American Spine Society; 2009: 1-98
  • 38 Hill J, Treasure T. ; National Clinical Guideline Centre for Acute and Chronic Conditions. Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance. BMJ 2010; 340: c95
  • 39 Aito S, Pieri A, D'Andrea M, Marcelli F, Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord 2002; 40 (06) 300-303
  • 40 Tracy BM, Dunne JR, O'Neal CM, Clayton E. Venous thromboembolism prophylaxis in neurosurgical trauma patients. J Surg Res 2016; 205 (01) 221-227
  • 41 DiGiorgio AM, Tsolinas R, Alazzeh M. , et al. Safety and effectiveness of early chemical deep venous thrombosis prophylaxis after spinal cord injury: pilot prospective data. Neurosurg Focus 2017; 43 (05) E21
  • 42 Zeeshan M, Khan M, O'Keeffe T. , et al. Optimal timing of initiation of thromboprophylaxis in spine trauma managed operatively: a nationwide propensity-matched analysis of trauma quality improvement program. J Trauma Acute Care Surg 2018; 85 (02) 387-392
  • 43 Arnold PM, Harrop JS, Merli G. , et al. Efficacy, safety, and timing of anticoagulant thromboprophylaxis for the prevention of venous thromboembolism in patients with acute spinal cord injury: a systematic review. Global Spine J 2017; 7 (3, Suppl): 138S-150S
  • 44 Godat LN, Kobayashi L, Chang DC, Coimbra R. Can we ever stop worrying about venous thromboembolism after trauma?. J Trauma Acute Care Surg 2015; 78 (03) 475-480 , discussion 480–481
  • 45 Maxwell RA, Chavarria-Aguilar M, Cockerham WT. , et al. Routine prophylactic vena cava filtration is not indicated after acute spinal cord injury. J Trauma 2002; 52 (05) 902-906
  • 46 Gorman PH, Qadri SF, Rao-Patel A. Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury. J Trauma 2009; 66 (03) 707-712
  • 47 Van Ha TG. Complications of inferior vena caval filters. Semin Intervent Radiol 2006; 23 (02) 150-155
  • 48 Streiff MB. Vena caval filters: a comprehensive review. Blood 2000; 95 (12) 3669-3677
  • 49 Wu A, Helo N, Moon E, Tam M, Kapoor B, Wang W. Strategies for prevention of iatrogenic inferior vena cava filter entrapment and dislodgement during central venous catheter placement. J Vasc Surg 2014; 59 (01) 255-259
  • 50 Credeur DP, Vana LM, Kelley ET, Stoner L, Dolbow DR. Effects of intermittent pneumatic compression on leg vascular function in people with spinal cord injury: a pilot study. J Spinal Cord Med 2017; •••: 1-9
  • 51 Merli GJ, Herbison GJ, Ditunno JF. , et al. Deep vein thrombosis: prophylaxis in acute spinal cord injured patients. Arch Phys Med Rehabil 1988; 69 (09) 661-664
  • 52 Ploumis A, Ponnappan RK, Maltenfort MG. , et al. Thromboprophylaxis in patients with acute spinal injuries: an evidence-based analysis. J Bone Joint Surg Am 2009; 91 (11) 2568-2576
  • 53 Godoy Monzon D, Iserson KV, Cid A, Vazquez JA. Oral thromboprophylaxis in pelvic trauma: a standardized protocol. J Emerg Med 2012; 43 (04) 612-617